365 related articles for article (PubMed ID: 18393141)
1. Are fibrin-related markers useful for the diagnosis of thrombosis?
Wada H; Sakuragawa N
Semin Thromb Hemost; 2008 Feb; 34(1):33-8. PubMed ID: 18393141
[TBL] [Abstract][Full Text] [Related]
2. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
Koga S
Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
[TBL] [Abstract][Full Text] [Related]
3. Elevated plasma levels of fibrin degradation products by granulocyte-derived elastase in patients with deep vein thrombosis.
Kamikura Y; Wada H; Nobori T; Matsumoto T; Shiku H; Ishikura K; Yamada N; Nakano T; Kazahaya Y; Sawai T; Matsuda M
Thromb Res; 2005; 115(1-2):53-7. PubMed ID: 15567453
[TBL] [Abstract][Full Text] [Related]
4. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
[TBL] [Abstract][Full Text] [Related]
5. The relationship of D-dimer levels with risk for developing deep-vein thrombosis and/or pulmonary thromboembolism after orthopaedic trauma surgery.
Naeem MA; Usman M; Latif MK; Aamir M
J Ayub Med Coll Abbottabad; 2009; 21(2):113-6. PubMed ID: 20524485
[TBL] [Abstract][Full Text] [Related]
6. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products.
Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H
Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232
[TBL] [Abstract][Full Text] [Related]
7. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
Dempfle CE
Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the cutoff values in fibrin-related markers for the diagnosis of overt DIC.
Hatada T; Wada H; Kawasugi K; Okamoto K; Uchiyama T; Kushimoto S; Seki Y; Okamura T; Imai H; Kaneko T; Nobori T;
Clin Appl Thromb Hemost; 2012 Sep; 18(5):495-500. PubMed ID: 22203032
[TBL] [Abstract][Full Text] [Related]
9. Elevated levels of soluble fibrin or D-dimer indicate high risk of thrombosis.
Wada H; Kobayashi T; Abe Y; Hatada T; Yamada N; Sudo A; Uchida A; Nobori T
J Thromb Haemost; 2006 Jun; 4(6):1253-8. PubMed ID: 16706968
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis.
Sidelmann JJ; Bladbjerg EM; Gram J; Münster AM; Jespersen J
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):405-9. PubMed ID: 18600090
[TBL] [Abstract][Full Text] [Related]
11. D-dimer assay for deep vein thrombosis. its role with colour Doppler sonography.
Evans SE; Davies RS; Harvey DJ
Clin Radiol; 2001 Aug; 56(8):689. PubMed ID: 11467878
[No Abstract] [Full Text] [Related]
12. Soluble fibrin monomer degradation products as a potentially useful marker for hypercoagulable states with accelerated fibrinolysis.
Ieko M; Nakabayashi T; Tarumi T; Naito S; Yoshida M; Kanazawa K; Mizukami K; Koike T
Clin Chim Acta; 2007; 386(1-2):38-45. PubMed ID: 17803984
[TBL] [Abstract][Full Text] [Related]
13. [Perioperative changes of the coagulation markers in patients undergoing hip fracture surgery].
Okamura K; Nakagawa I; Hidaka S; Okada Y; Kubo T; Kato T
Masui; 2007 Nov; 56(11):1353-7. PubMed ID: 18027607
[TBL] [Abstract][Full Text] [Related]
14. [Clinical use of D-dimer testing].
Lachâtre F; Gothot A
Rev Med Liege; 2007 Jan; 62(1):29-35. PubMed ID: 17343127
[TBL] [Abstract][Full Text] [Related]
15. Limited usefulness of D-dimer in suspected deep vein thrombosis of the upper extremities.
Merminod T; Pellicciotta S; Bounameaux H
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):225-6. PubMed ID: 16575263
[No Abstract] [Full Text] [Related]
16. The relationships among hemostatic markers, the withdrawal of fondaparinux due to a reduction in hemoglobin and deep vein thrombosis in Japanese patients undergoing major orthopedic surgery.
Hasegawa M; Wada H; Wakabayashi H; Yoshida K; Miyamoto N; Asanuma K; Matsumoto T; Ohishi K; Shimokariya Y; Yamada N; Uchida A; Sudo A
Clin Chim Acta; 2013 Oct; 425():109-13. PubMed ID: 23876378
[TBL] [Abstract][Full Text] [Related]
17. [Pre-Thrombotic (Hypercoagulable) State/Hypercoagulable Disease].
Wada H
Rinsho Byori; 2015 Dec; 63(12):1405-11. PubMed ID: 27089657
[TBL] [Abstract][Full Text] [Related]
18. Elevated fibrin-related markers in patients with malignant diseases frequently associated with disseminated intravascular coagulation and venous thromboembolism.
Yamashita Y; Wada H; Nomura H; Mizuno T; Saito K; Yamada N; Asanuma K; Usui M; Kamimoto Y; Matsumoto T; Ohishi K; Katayama N
Intern Med; 2014; 53(5):413-9. PubMed ID: 24583428
[TBL] [Abstract][Full Text] [Related]
19. D-dimer testing in ischemic stroke and cerebral sinus and venous thrombosis.
Squizzato A; Ageno W
Semin Vasc Med; 2005 Nov; 5(4):379-86. PubMed ID: 16302160
[TBL] [Abstract][Full Text] [Related]
20. [Clinical significance of cross linked fibrin degradation products in thrombotic disorders].
Koyama T; Oura Y; Higuchi M; Kakishita E; Nagai K
Rinsho Ketsueki; 1989 May; 30(5):659-62. PubMed ID: 2677436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
